TAS-102 Adverse events compared to other approved flouropyrmidines

TAS-102 Adverse events compared to other approved flouropyrmidines

267 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Alan P. Venook, MD of University of California San Francisco discusses TAS-102 Adverse events compared to other approved flouropyrmidines at ASCO GI 2016
Up Next Autoplay